1. A multicentre prospective study response to treatment in genotype 3 and 1b infected patients with sickest liver cirrhosis: SVR 4 is not a reliable measure. (8th October 2016) Authors: Persico, M.; Rendina, M.; Di Marco, V.; Aghemo, A.; Brunetto, M.; Ciancio, A.; Zuin, M.; Andreone, P.; Villa, E.; Calvaruso, V.; De Nicola, S.; Coco, B.; Aglitti, A.; Toshina, Y.; Giorgini, A.; Conti, F.; Marzi, L.; Lleo, A.; Bollani, S.; Di Leo, A. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 3 Page Start: e233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adaptive response in hepatitis B virus infection. Issue 5 (27th March 2014) Authors: Loggi, E.; Gamal, N.; Bihl, F.; Bernardi, M.; Andreone, P. Journal: Journal of viral hepatitis Issue: Volume 21:Issue 5(2014) Page Start: 305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Analysis of resistance and phylogenetic clusters in HCV-2c infected patients within the Italian network Vironet C. (February 2020) Authors: Barbaliscia, S.; Di Maio, V.C.; Fabeni, L.; Teti, E.; Paolucci, S.; Minichini, C.; Aragri, M.; Rosa, K. Yu La; Carioti, L.; Pasquazzi, C.; Milana, M.; Foroghi, L.; Pollicino, T.; Licata, A.; Pieri, A.; Palitti, V. Pace; Bruzzone, B.; Micheli, V.; Bertoli, A.; Baiocchi, L. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis. (February 2019) Authors: Pettinari, I.; Vukotic, R.; Stefanescu, H.; Pecorelli, A.; Morelli, Mc; Grigoras, C.; Sparchez, Z.; Andreone, P.; Piscaglia, F. Journal: American journal of gastroenterology Issue: Volume 114:Number 2(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods. Issue 1 (16th February 2017) Authors: Ravaioli, F.; Tamè, M.R.; Marasco, G.; Vizioli, L.; Morelli, M.C.; Pinna, A.D.; Conti, F.; Andreone, P.; Colecchia, A.; Festi, D. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin. Issue 4 (14th February 2013) Authors: Foster, G. R.; Zeuzem, S.; Pianko, S.; Sarin, S. K.; Piratvisuth, T.; Shah, S.; Andreone, P.; Sood, A.; Chuang, W.‐L.; Lee, C.‐M.; George, J.; Gould, M.; Flisiak, R.; Jacobson, I. M.; Komolmit, P.; Thongsawat, S.; Tanwandee, T.; Rasenack, J.; Sola, R.; Messina, I. Journal: Journal of viral hepatitis Issue: Volume 20:Issue 4(2013) Page Start: e115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Diagnostic accuracy of liver and spleen stiffness measurement for portal hypertension using bidimensional shear weave elastography. (15th February 2015) Authors: Stefanescu, H.; Procopet, B.; Allegretti, G.; Berzigotti, A.; Gamal, N.; Conti, F.; Festi, D.; Andreone, P.; Bolondi, L.; Bosch, J.; Piscaglia, F. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 1 Page Start: e18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Direct acting antiviral (DAA) therapy of HCV, effects on the cryoglobulinemic vasculitis: A multi center open label study. Issue 1 (16th February 2017) Authors: Mauro, E.; Quartuccio, L.; Ghersetti, M.; Lenzi, M.; Gitto, S.; Andreone, P.; Casarin, P.; De Vita, S.; Pozzato, G.; Mazzaro, C. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice. (10th February 2016) Authors: Conti, F.; Scuteri, A.; Vitale, G.; Lazzarini, G.; Porro, A.; Muratori, P.; Serio, I.; Buonfiglioli, F.; Badia, L.; Lanzi, A.; Mastroroberto, M.; Appolloni, L.; Morotti, M.; Morelli, M.C.; Foschi, F.G.; Verucchi, G.; Brillanti, S.; Crespi, C.; Lenzi, M.; Mazzella, G. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 1 Page Start: e4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Durable response in the markers of cholestasis through 18 months of open-label extension with obeticholic acid in primary biliary cholangitis. (8th October 2016) Authors: Trauner, M.; Nevens, F.; Andreone, P.; Mazzella, G.; Strasser, S.; Bowlus, C.; Invernizzi, P.; Drenth, J.; Pockros, P.; Regula, J.; Floreani, A.; Hohenester, S.; Luketic, V.; Shiffman, M.; van Erpecum, K.; Vargas, V.; Vincent, C.; Hansen, B.; MacConell, L.; Marmon, T. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 3 Page Start: e236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗